메뉴 건너뛰기
Movement Disorders
Volumn 25, Issue 12, 2010, Pages 1994-1995
Clozapine for medication-related pathological gambling in Parkinson disease
Author keywords

[No Author keywords available]
Indexed keywords

ALPRAZOLAM; CABERGOLINE; CLOZAPINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PRAMIPEXOLE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;
EID: 77956831215     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23177     Document Type: Letter
Times cited : (38)
References (10)
  • 1
    • 0004235298 scopus 로고    scopus 로고
    • DSM-IV-TR. Fourth ed, Text Revision. Washigton, D.C. American Psychiatric Association
    • DSM-IV-TR. Diagnostic and statistical manual of mental disorders, Fourth ed, Text Revision. Washigton, D.C. American Psychiatric Association, 2000.
    • (2000) Diagnostic and Statistical Manual of Mental Disorders
  • 2
    • 34547862721 scopus 로고    scopus 로고
    • Medication-related impulse control and repetitive behaviors in Parkinson disease
    • DOI 10.1001/archneur.64.8.1089
    • Voon V, Fox SH. Medication-related impulse control and repetitive behaviours in Parkinson disease. Arch Neurol 2007;64:1089-1096. (Pubitemid 47258066)
    • (2007) Archives of Neurology , vol.64 , Issue.8 , pp. 1089-1096
    • Voon, V.1    Fox, S.H.2
  • 3
    • 64749086508 scopus 로고    scopus 로고
    • Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease
    • Bostwick JM, Hecksel KA, Stevens SR, Bower JH, Ahlskog JE. Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease. Mayo Clin Proc 2009;84:310-316.
    • (2009) Mayo Clin Proc , vol.84 , pp. 310-316
    • Bostwick, J.M.1    Hecksel, K.A.2    Stevens, S.R.3    Bower, J.H.4    Ahlskog, J.E.5
  • 4
    • 2342420478 scopus 로고    scopus 로고
    • Disabling repetitive behaviors in Parkinson's disease
    • DOI 10.1002/mds.10625
    • Kurlan R. Disabling repetitive behaviours in Parkinson's disease. Mov Disord 2004;19:433-437. (Pubitemid 38559646)
    • (2004) Movement Disorders , vol.19 , Issue.4 , pp. 433-437
    • Kurlan, R.1
  • 5
    • 0033863901 scopus 로고    scopus 로고
    • Pathological gambling behaviour: Emergence secondary to treatment of Parkinson's disease with dopaminergic agents
    • Seedat S, Kesler S, Niehaus Dj, Stein DJ. Pathological gambling behaviour: emergence secondary to treatment of Parkinson's disease with dopaminergic agents. Depress Anxiety 2000;11:185-186.
    • (2000) Depress Anxiety , vol.11 , pp. 185-186
    • Seedat, S.1    Kesler, S.2    Dj, N.3    Stein, D.J.4
  • 6
    • 33846252266 scopus 로고    scopus 로고
    • Quetiapine in a case with parkinson disease and pathological gambling [13]
    • DOI 10.1097/JCP.0b013e31802e98c3, PII 0000471420070200000030
    • Sevincok L, Akoglu A, Akyol A. Quetiapine in a case with Parkinson's disease and pathological gambling. J Clin Psychopharmacol 2007;27:107-108. (Pubitemid 46105785)
    • (2007) Journal of Clinical Psychopharmacology , vol.27 , Issue.1 , pp. 107-108
    • Sevincok, L.1    Akoglu, A.2    Akyol, A.3
  • 8
    • 13844322012 scopus 로고    scopus 로고
    • The use o aripiprazole in obsessive-compulsive disorder: Preliminary observations in 8 patients
    • Connor KM, Payne VM, Gadde KM, Zhang W, Davidson JRT. The use o aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients. J Clin Psychiatry 2005;66: 49-51.
    • (2005) J Clin Psychiatry , vol.66 , pp. 49-51
    • Connor, K.M.1    Payne, V.M.2    Gadde, K.M.3    Zhang, W.4    Davidson, J.R.T.5
  • 9
    • 76749108953 scopus 로고    scopus 로고
    • Current use of clozapine in Parkinson disease and related disorders
    • Thomas AA, Friedman JH. Current use of clozapine in Parkinson disease and related disorders. Clin Neuropharmacol 2010;33:14-16.
    • (2010) Clin Neuropharmacol , vol.33 , pp. 14-16
    • Thomas, A.A.1    Friedman, J.H.2
  • 10
    • 27744476275 scopus 로고    scopus 로고
    • 3 partial agonist
    • 3 partial agonist. JPET 2005;315: 1278-1287.
    • (2005) JPET , vol.315 , pp. 1278-1287

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.